Study finds protein variant that renders chemotherapy ineffe

A study by a multidisciplinary team at Weill Cornell Medicine has identified a new protein variant that underlies the ability of gastric cancers to resist an ot

Related Keywords

Israel , Washington , United States , Olivier Elemento , Manish Shah , Paraskevi Giannakakou , Israel Englander Institute For Precision Medicine , Solid Tumor Oncology Service , Presbyterian Weill Cornell Medical Center , Meyer Cancer Center At Weill Cornell Medicine , Gastrointestinal Oncology Program , Division Of Hematology , Weill Cornell Medicine , Medical Oncology , Edward Meyer Cancer Center , Weill Cornell , Weill Cornell Medical Center , Bartlett Family Professor , Gastrointestinal Oncology , Meyer Cancer Center , Israel Englander Institute , Precision Medicine , Computational Biomedicine , Onethree Biotech , Advanced Digestive Care , Weill Cornell Medical , Medical News , Resbyterian Weill , Cornell Medical , Molecules , Problem , Professor , Variant That , Dancer , Program , Treatment ,